Cargando…

PET imaging of an optimized anti-PD-L1 probe (68)Ga-NODAGA-BMS986192 in immunocompetent mice and non-human primates

BACKGROUND: Adnectin is a protein family derived from the 10th type III domain of human fibronectin ((10)Fn3) with high-affinity targeting capabilities. Positron emission tomography (PET) probes derived from anti-programmed death ligand-1 (PD-L1) Adnectins, including (18)F- and (68)Ga-labeled BMS-98...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Huimin, Bao, Guangfa, Wang, Ziqiang, Zhang, Buchuan, Li, Dan, Chen, Lixing, Deng, Xiaoyun, Yu, Bo, Zhao, Jun, Zhu, Xiaohua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9192916/ https://www.ncbi.nlm.nih.gov/pubmed/35695985 http://dx.doi.org/10.1186/s13550-022-00906-x

Ejemplares similares

PET Probes for Preclinical Imaging of GRPR-Positive Prostate Cancer: Comparative Preclinical Study of [(68)Ga]Ga-NODAGA-AMBA and [(44)Sc]Sc-NODAGA-AMBA
por: Kálmán-Szabó, Ibolya, et al.
Publicado: (2022)

First in-human radiation dosimetry of (68)Ga-NODAGA-RGDyK
por: Gnesin, Silvano, et al.
Publicado: (2017)

Evaluation of [(68)Ga]Ga-NODAGA-RGD for PET Imaging of Rat Autoimmune Myocarditis
por: Jahandideh, Arghavan, et al.
Publicado: (2021)

(18)F-BMS986192 PET Imaging of PD-L1 in Metastatic Melanoma Patients with Brain Metastases Treated with Immune Checkpoint Inhibitors: A Pilot Study
por: Nienhuis, Pieter H., et al.
Publicado: (2022)

(68)Ga-NODAGA-Exendin-4 PET/CT Improves the Detection of Focal Congenital Hyperinsulinism
por: Boss, Marti, et al.
Publicado: (2022)

Preparation, Characterization, and Radiolabeling of [(68)Ga]Ga-NODAGA-Pamidronic Acid: A Potential PET Bone Imaging Agent
por: Ashhar, Zarif, et al.
Publicado: (2020)

In Vivo Imaging of Experimental Melanoma Tumors using the Novel Radiotracer (68)Ga-NODAGA-Procainamide (PCA)
por: Kertész, István, et al.
Publicado: (2017)

Brain Imaging of the GLP-1 Receptor in Obesity Using (68)Ga-NODAGA-Exendin-4 PET
por: Deden, Laura N., et al.
Publicado: (2021)

Human Dose Assessment of (68)Ga-NODAGA-RGD-BBN Heterodimer Peptide based on Animal Data
por: Amraee, Naeimeh, et al.
Publicado: (2022)

Comparison of Ga-68-Labeled Fusarinine C-Based Multivalent RGD Conjugates and [(68)Ga]NODAGA-RGD—In Vivo Imaging Studies in Human Xenograft Tumors
por: Zhai, Chuangyan, et al.
Publicado: (2016)

PET-Based Human Dosimetry of (68)Ga-NODAGA-Exendin-4, a Tracer for β-Cell Imaging
por: Boss, Marti, et al.
Publicado: (2020)

Comparison of desferrioxamine and NODAGA for the gallium-68 labeling of exendin-4
por: Kaeppeli, Simon A. M., et al.
Publicado: (2019)

[(68)Ga]Ga-NODAGA-E[(cRGDyK)](2) Angiogenesis PET/MR in a Porcine Model of Chronic Myocardial Infarction
por: Bentsen, Simon, et al.
Publicado: (2021)

[(68)Ga]Ga-NODAGA-E[(cRGDyK)](2) and [(64)Cu]Cu-DOTATATE PET Predict Improvement in Ischemic Cardiomyopathy
por: Follin, Bjarke, et al.
Publicado: (2023)

[(68)Ga]NODAGA-RGD – Metabolic stability, biodistribution, and dosimetry data from patients with hepatocellular carcinoma and liver cirrhosis
por: Haubner, Roland, et al.
Publicado: (2016)

PET imaging of (68)Ga-NODAGA-RGD, as compared with (18)F-fluorodeoxyglucose, in experimental rodent models of engrafted glioblastoma
por: Isal, Sibel, et al.
Publicado: (2018)

First in-human radiation dosimetry of the gastrin-releasing peptide (GRP) receptor antagonist (68)Ga-NODAGA-MJ9
por: Gnesin, Silvano, et al.
Publicado: (2018)

Angiogenesis PET Tracer Uptake ((68)Ga-NODAGA-E[(cRGDyK)](2)) in Induced Myocardial Infarction in Minipigs
por: Rasmussen, Thomas, et al.
Publicado: (2016)

Imaging angiogenesis in atherosclerosis in large arteries with (68)Ga-NODAGA-RGD PET/CT: relationship with clinical atherosclerotic cardiovascular disease
por: Dietz, Matthieu, et al.
Publicado: (2021)

Development and Validation of an Analytical HPLC Method to Assess Chemical and Radiochemical Purity of [(68)Ga]Ga-NODAGA-Exendin-4 Produced by a Fully Automated Method
por: Migliari, Silvia, et al.
Publicado: (2022)

Imaging of α(v)β(3) integrin expression in experimental myocardial ischemia with [(68)Ga]NODAGA-RGD positron emission tomography
por: Grönman, Maria, et al.
Publicado: (2017)

Association between [(68)Ga]NODAGA-RGDyK uptake and dynamics of angiogenesis in a human cell-based 3D model
por: Grönman, Maria, et al.
Publicado: (2021)

Head and neck tumors angiogenesis imaging with (68)Ga-NODAGA-RGD in comparison to (18)F-FDG PET/CT: a pilot study
por: Durante, Steve, et al.
Publicado: (2020)

Angiogenesis PET Tracer Uptake ((68)Ga-NODAGA-E[(cRGDyK)](2)) in Induced Myocardial Infarction and Stromal Cell Treatment in Minipigs
por: Rasmussen, Thomas, et al.
Publicado: (2018)

The Role of Glucagon-Like Peptide 1 Receptor PET/CT With Ga-68-NODAGA-exendin in Localising an Insulinoma: Lessons From a Clinical Case
por: Grigoriadou, Viktoria Chatzimavridou, et al.
Publicado: (2021)

Angiogenesis Imaging of Adrenocortical Carcinoma with Ga-68-NODAGA-RGD Positron Emission Tomography: Opening New Horizons in Multimodality Imaging from Theranostic Perspective
por: Verma, Priyanka, et al.
Publicado: (2023)

Glucagon-like peptide-1 receptor expression after myocardial infarction: Imaging study using (68)Ga-NODAGA-exendin-4 positron emission tomography
por: Ståhle, Mia, et al.
Publicado: (2018)

[(68)Ga]Ga-NODAGA-E[(cRGDyK)](2) angiogenesis PET following myocardial infarction in an experimental rat model predicts cardiac functional parameters and development of heart failure
por: Bentsen, Simon, et al.
Publicado: (2023)

A comparison of three (67/68)Ga-labelled exendin-4 derivatives for β-cell imaging on the GLP-1 receptor: the influence of the conjugation site of NODAGA as chelator
por: Jodal, Andreas, et al.
Publicado: (2014)

In Vivo Molecular Imaging of the Efficacy of Aminopeptidase N (APN/CD13) Receptor Inhibitor Treatment on Experimental Tumors Using (68)Ga-NODAGA-c(NGR) Peptide
por: Kis, Adrienn, et al.
Publicado: (2021)

Synthesis of Novel, Dual-Targeting (68)Ga-NODAGA-LacN-E[c(RGDfK)](2) Glycopeptide as a PET Imaging Agent for Cancer Diagnosis
por: Gyuricza, Barbara, et al.
Publicado: (2021)

Dapagliflozin: BMS 512148; BMS-512148
Publicado: (2012)

[(68)Ga]Ga-NODAGA-E[(cRGDyK)](2) PET and hyperpolarized [1-(13)C] pyruvate MRSI (hyperPET) in canine cancer patients: simultaneous imaging of angiogenesis and the Warburg effect
por: Clemmensen, Andreas, et al.
Publicado: (2020)

Development of (68)Ga-Glycopeptide as an Imaging Probe for Tumor Angiogenesis
por: Tsao, Ning, et al.
Publicado: (2011)

[(68)Ga]-NODAGA-RGD Positron Emission Tomography (PET) for Assessment of Post Myocardial Infarction Angiogenesis as a Predictor for Left Ventricular Remodeling in Mice after Cardiac Stem Cell Therapy
por: Lang, Cajetan Immanuel, et al.
Publicado: (2020)

Comparison of integrin α(v)β(3) expression with (68)Ga-NODAGA-RGD PET/CT and glucose metabolism with (18)F-FDG PET/CT in esophageal or gastroesophageal junction cancers
por: Dietz, Matthieu, et al.
Publicado: (2023)

First-in-Human Study of [(68)Ga]Ga-NODAGA-E[c(RGDyK)](2) PET for Integrin α(v)β(3) Imaging in Patients with Breast Cancer and Neuroendocrine Neoplasms: Safety, Dosimetry and Tumor Imaging Ability
por: Clausen, Malene Martini, et al.
Publicado: (2022)

Cyclotron-based production of (68)Ga, [(68)Ga]GaCl(3), and [(68)Ga]Ga-PSMA-11 from a liquid target
por: Rodnick, Melissa E., et al.
Publicado: (2020)

Meningiomas: A Comparative Study of (68)Ga-DOTATOC, (68)Ga-DOTANOC and (68)Ga-DOTATATE for Molecular Imaging in Mice
por: Soto-Montenegro, María Luisa, et al.
Publicado: (2014)

Automated GMP Production and Preclinical Evaluation of [(68)Ga]Ga-TEoS-DAZA and [(68)Ga]Ga-TMoS-DAZA
por: Greiser, Julia, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_hfrptvqpl71rfs7262aijcf9c3